Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 2001

View Archived Issues

Researchers reveal crystal structure of antibody against HIV

Testosterone protects human primary neurons from apoptosis

Hormone replacement therapy has osteoprotective effects in elderly women

Ultracet combination analgesic approved by FDA for acute pain relief

Seattle Genetics initiates phase II trial with SGN-15

Chrysalis reports positive trends from pilot Chrysalin clinical trial for diabetic ulcers

Immunex and Wyeth-Ayerst to commence longitudinal rheumatoid arthritis study

Novogen to initiate clinical trial of oral phenoxodiol in advanced prostate cancer

Ivax announces encouraging phase I results of BNP-166 as treatment of Crohn's disease

Biomira and Merck KGaA to meet with FDA regarding Theratope vaccine

Visudyne approved for additional ocular conditions in the U.S.

Enrollment for study of Zadaxin in hepatitis B in Japan completed

Lilly and Isis establish antisense strategic alliance

Study of Cytran's IM-862 in ovarian cancer begins at Magee-Womens Hospital

Revised Remicade label strengthens warnings about risk of infections

Schering-Plough highlights next-generation farnesyl protein transferase inhibitors at ACS meeting

Patient dosing completed in phase II study of Alista for treatment of FSD

Selective beta3-adrenoceptor agonists designed at Asahi Kasei

Sterix patents novel steroid sulfatase inhibitors

Potent inhibitors of IL-5 gene expression identified at Abbott

Jenapharm reports compounds with affinity for progesterone and/or glucocorticoid receptors

New series of inhibitors of TNF production may be useful as immunosuppressants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...